Mercantil Bank Holding Cl B (AMTBB)

28.72  -0.33 (-1.14%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AMTBB. AMTBB was compared to 412 industry peers in the Banks industry. AMTBB has a bad profitability rating. Also its financial health evaluation is rather negative. AMTBB is quite expensive at the moment. It does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

AMTBB had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA 0.75%
ROE 6.87%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AMTBB does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 22.12%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

The number of shares outstanding for AMTBB has been reduced compared to 1 year ago.
AMTBB has a worse debt/assets ratio than last year.

2.2 Solvency

A Debt/Equity ratio of 0.15 indicates that AMTBB is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1937.50% over the past year.
The Revenue has decreased by -6.38% in the past year.
Measured over the past years, AMTBB shows a small growth in Revenue. The Revenue has been growing by 2.99% on average per year.
EPS 1Y (TTM)1937.5%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q600%
Revenue 1Y (TTM)-6.38%
Revenue growth 3Y-2.19%
Revenue growth 5Y2.99%
Revenue growth Q2Q-0.59%

3.2 Future

The Earnings Per Share is expected to grow by 99.39% on average over the next years. This is a very strong growth
AMTBB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.84% yearly.
EPS Next Y1788.1%
EPS Next 2Y361.65%
EPS Next 3Y190.61%
EPS Next 5Y99.39%
Revenue Next Year-2.71%
Revenue Next 2Y1.88%
Revenue Next 3Y3.88%
Revenue Next 5Y4.84%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 19.54, AMTBB is valued on the expensive side.
AMTBB's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.28.
AMTBB is valuated correctly with a Price/Forward Earnings ratio of 14.87.
AMTBB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.88, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.54
Fwd PE 14.87

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AMTBB's earnings are expected to grow with 190.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y361.65%
EPS Next 3Y190.61%

0

5. Dividend

5.1 Amount

No dividends for AMTBB!.
Industry RankSector Rank
Dividend Yield N/A

Mercantil Bank Holding Cl B

NASDAQ:AMTBB (11/17/2021, 7:16:39 PM)

28.72

-0.33 (-1.14%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.08B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 19.54
Fwd PE 14.87
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.75%
ROE 6.87%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 22.12%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)1937.5%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y1788.1%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-6.38%
Revenue growth 3Y-2.19%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y